Literature DB >> 18673185

Engineering silica particles as oral drug delivery vehicles.

S P Rigby1, M Fairhead, C F van der Walle.   

Abstract

Porous silica particles are emerging as complementary systems to polyester microspheres for the encapsulation and controlled delivery of small-organic drugs. Their recent application in pharmaceutics is strengthened by well-established characterization and synthetic routes from the chemical engineering sciences. Silica is an interesting scaffold material for the encapsulation of organic molecules. It can be formed into hierarchical structures over a wide range of length scales and interconnectivities. Encapsulation can therefore be tailored not only to the drug but the desired release properties. In addition to surfactant-templating of hierarchical silica structures, polypeptides from marine organisms may offer biological routes to novel silica materials. Silica sol-gels have also been evaluated as delivery vehicles, particularly with regard to generating hybrid systems with mesoporous silica or composite xerogels. This review will first focus on the detailed characterisation of pore size and structure of mesoporous silica with regards water penetration and drug diffusion. We then describe the pharmaceutical applications of silica materials with regard to improving oral bioavailability, multiparticulate systems for gastroretention or sustained release, composite xerogels and in vivo biocompatibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18673185     DOI: 10.2174/138161208784746671

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria.

Authors:  Tse Siang Kang; Lin Wang; Christineh N Sarkissian; Alejandra Gámez; Charles R Scriver; Raymond C Stevens
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797

Review 2.  Microalgae: therapeutic potentials and applications.

Authors:  Fatemeh Khavari; Massoud Saidijam; Mohammad Taheri; Fatemeh Nouri
Journal:  Mol Biol Rep       Date:  2021-05-24       Impact factor: 2.316

3.  Multimodality Imaging of Integrin α(v)β(3) Expression.

Authors:  Yin Zhang; Yunan Yang; Weibo Cai
Journal:  Theranostics       Date:  2011-02-10       Impact factor: 11.556

4.  Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles.

Authors:  Diti Desai; Neeraj Prabhakar; Veronika Mamaeva; Didem Şen Karaman; Iris A K Lähdeniemi; Cecilia Sahlgren; Jessica M Rosenholm; Diana M Toivola
Journal:  Int J Nanomedicine       Date:  2016-01-18

5.  Synthesis and characterization of a modified surface of SBA-15 mesoporous silica for a chloramphenicol drug delivery system.

Authors:  Talib M Albayati; Issam K Salih; Haneen F Alazzawi
Journal:  Heliyon       Date:  2019-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.